José Ramón Paño‐Pardo

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

ESCMID COVID-19 living guidelines: drug treatment and clinical management

Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać et al. · Clinical Microbiology and Infection · 2021 · 180 citations · Full text

Pharmacy, Pharmacotherapy, Palliative Medicine +5

Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients

Juan José Castón, Isabel Lacort-Peralta, Pilar Martín‐Dávila et al. · International Journal of Infectious Diseases · 2017 · 153 citations · Full text

Pharmacy, Hematology, Infectious Diseases +17

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · Mayo Clinic Proceedings · 2016 · 117 citations

Life Sciences, Infectious Diseases, Microbiology +16

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

C. Avendaño, António Ramos, Elena Múñez et al. · Journal of Clinical Investigation · 2021 · 110 citations · Full text

Life Sciences, Immunology, Infectious Diseases +7